Dossier · RKLB · Recently exited
RKLB · Rocket Lab Corporation · Stock research
Last analysed ·
Resolved Graded and closed 2026-05-19 at medium conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-08-25 and is not part of the scored record. Research has since re-rated the name low; the record keeps the graded tier.
Current thesis
Defense-backlog re-fire interrupts the mid-July rollover: the 7/20 $17B NSSL Phase 3 Lane 1 qualification and 7/21 $266M suborbital award stabilized the tape after the 7/13 support break and Piper's 7/16 Neutral $83 cap. An unresolved $3.6B bridge + $3B ATM dilution overhang and a ~8/7 Q2 binary sit under any fresh entry; maturing theme bouncing off a broken structure, confirm rather than chase.
Kill line
A weekly close below $105 loses the post-Iridium deal base and hands the tape back to the pre-announcement range; a $3B-ATM equity take-out of the $3.6B bridge, or space-ETF (UFO/FSPC) inflows rolling over as NSSL task orders fail to convert, would remove the remaining passive and backlog bid.
Pick status
Invalidated resolved published kill line fired graded at medium · since re-rated low How this is scored →Latest analysis and events for RKLB —
As of 25 August 2026, the latest FrontierPicks analysis for Rocket Lab Corporation (RKLB): 16 July 2026: Piper Sandler initiated Neutral, PT $83 — FIRST post-Iridium coverage launch and it landed BELOW spot and below the entire 6-raise June 30 cluster ($96 Cantor floor, $130 Citizens/Roth ceiling). Target band now brackets price instead of sitting above it. A second Neutral or a downgrade from an existing bull confirms the raise cycle is over.
Kill line: A weekly close below $105 loses the post-Iridium deal base and hands the tape back to the pre-announcement range; a $3B-ATM equity take-out of the $3.6B bridge, or space-ETF (UFO/FSPC) inflows rolling over as NSSL task orders fail to convert, would remove the remaining passive and backlog bid.
Next dated event on file: — catalyst in 29d.
Reference close 2026-08-24: $68.28 (split/dividend-adjusted daily bars). 54.5% below the $150.23 adjusted 52-week high; the shares are down 52.3% over three months; RSI(14) 39.4.
RKLB — Rocket Lab Corporation
Current Thesis
Two items dated 2026-08-24 cut the same way. The S-4/A filed that day fixed the Iridium special meeting for 2026-09-24, 8:30 a.m. ET, virtual, with a record date of 2026-08-21 and 105,981,552 Iridium shares outstanding — the bracketed placeholder carried in the 2026-08-13 S-4 is now a calendar date. On the same day, CFO Adam Spice framed the profitability path as "really getting that first Neutron launch off," with positive adjusted EBITDA expected in the quarter after a successful test flight, while CEO Peter Beck said the window for an end-of-year launch is narrowing. Shares fell 5.9% to $68.28, a fifth straight lower close after four consecutive declines into 2026-08-21.
That close has mechanical weight. The stock leg of the Iridium consideration is a collared exchange ratio — 0.4000 RKLB shares if the reference price is at or below $67.50, 0.2400 at or above $112.50, floating in between at $27.00 divided by the reference price, on top of $27.00 cash. Per the S-4/the reference price is a ten-day VWAP ending on the second full trading day before the first effective time, so it is measured at closing (targeted mid-2027), not at the September vote. Price now sits within a dollar of the floor of that collar, which is the maximum-share-issuance end of the deal.
The leg an investor is buying is unchanged from prior coverage and still concrete: backlog compounding faster than revenue ($2.36B, +137% year over year at the 2026-08-10 print), a defense order book widening through August, and a policy regime rewritten on 2026-08-20 to reward launch cadence. What has changed is that the equity now prices the financing before the franchise.
The narrative is saturated. The dates carry the label. Between 2026-08-17 and 2026-08-21 the name absorbed a NITE-STAR IDIQ onboarding, a Viasat sub-selection, two SDN-B delivery orders, the 93rd Electron flight, Goldman Sachs's $1.8-trillion-by-2035 framing and the first National Space Transportation Policy rewrite since 2013-11-21 — and closed lower across the run, then 5.9% lower again on 2026-08-24. Fourteen of eighteen covering analysts sit at Buy or better with a median target of $120. Near-unanimous sell-side support plus generalist framing plus policy tailwind, against a tape that will not hold a bid, is the signature of a crowded story trading out of its own supply. Revenue of $234.07M, +62% year over year, is why the label is not dead.
Bullish and bearish views on Rocket Lab Corporation
The model's bull view on Rocket Lab Corporation (RKLB), in brief: 2026-08-10 (Q2 FY26): revenue $234.07M, +62% YoY, against $231.35M consensus; GAAP gross margin 36.1%; cash and equivalents $2.129B; backlog a record $2.36B, +137% YoY. The bear view: 2026-08-24: Beck's "the window for an end-of-year launch is narrowing" is the third public softening of Neutron timing — pad delivery moved from 2025, then from mid-2026 after the January Stage 1 tank rupture at Wallops, and now the Q4 2026 target is qualified by management… Both cases follow in full.
Bull Case
- 2026-08-10 (Q2 FY26): revenue $234.07M, +62% YoY, against $231.35M consensus; GAAP gross margin 36.1%; cash and equivalents $2.129B; backlog a record $2.36B, +137% YoY. Q3 guided $250–265M versus roughly $238.53M consensus — a guide above the street.
- 2026-08-24: management attached a dated, falsifiable condition to profitability — positive adjusted EBITDA in the quarter following the first successful Neutron flight (CFO Adam Spice). That converts an open-ended cash-burn debate into one event.
- 2026-08-17/18: three defense datapoints in two sessions — onboarding to the U.S. Space Force NITE-STAR IDIQ ($981M shared ceiling, alongside Boeing, Lockheed Martin, Northrop Grumman), two SDN-B delivery orders totalling $12M, and Viasat's sub-selection of Rocket Lab for a Protected Tactical SATCOM-Global satellite bus.
- 2026-08-20: 93rd Electron mission deployed the latest QPS-SAR satellite for iQPS — the 14th Electron of 2026, ninth QPS-SAR deployment, with nine dedicated iQPS launches booked through 2030. Electron is the only segment producing flight evidence while Neutron is pre-debut.
- 2026-08-17: Cantor Fitzgerald raised its target from $96 to $122. Published coverage stands at 18 analysts (11 Strong Buy, 3 Buy, 4 Hold, 0 Sell), average 12-month target $112.94, median $120, high $150, low $64 (stockanalysis.com, retrieved 2026-08-24).
- 2026-08-20: NSPM-17 targets more than 1,000 U.S. launches and reentries annually by 2030, with faster permitting and new federal launch sites named as mechanisms.
Bear Case
- 2026-08-24: Beck's "the window for an end-of-year launch is narrowing" is the third public softening of Neutron timing — pad delivery moved from 2025, then from mid-2026 after the January Stage 1 tank rupture at Wallops, and now the Q4 2026 target is qualified by management itself.
- Equity supply is committed, not hypothetical. A replacement at-the-market programme of up to $1,944,369,826 was signed 2026-08-13, with proceeds intended for the Iridium cash consideration and to reduce the $3.6B senior secured bridge. Common shares went from 543,574,552 at 2025-12-31 to 598,180,438 at 2026-06-30; guided Q3 basic weighted shares are 641M, including roughly 41M preferred.
- The collar floor is now live. At a reference price at or below $67.50 the exchange ratio pins at 0.4000 — the largest share count the deal can issue. The last close was $68.28.
- Carry precedes revenue. The bridge is drawn against a mid-2027 close and a 2027-06-28 outside date; guided Q3 net interest income was $21M, a figure that inverts as the facility draws.
- Third-party valuation dissent: GuruFocus's GF Value model published a fair value of $37.47 against the $68.28 close on the day of the 5.9% decline. Screens surfaced on 2026-08-25 also put trailing-twelve-month insider sales near $923.8M with no open-market purchases; the underlying Form 4 detail is not verified here and is the check a reader should run.
Setup & Price Structure
The $105 weekly shelf flagged in prior coverage is gone and is now overhead supply, not support. Below it there is no base yet: RSI(14) at 39.4 has not reached oversold, and the tape has produced five consecutive lower closes into 2026-08-24. The drawdown is from a high rather than a round trip — Yahoo Finance reported on 2026-08-24 that the shares remain up roughly 75% over the trailing year — so long-held stock above is not underwater on a one-year view, which is a source of patient supply rather than forced selling.
The levels that carry information are contractual as much as technical. $67.50 is the collar floor written into the merger agreement; $64 is the low end of the published 18-analyst target band, and a weekly close beneath it would put the tape under every posted 12-month estimate. Five-year beta of 2.63 means the name moves several percent on macro days alone — long-end Treasury yields snapped back toward 20-month highs on 2026-08-20, the same week the policy headline landed and did not stick.
On crowding: there is no earnings print inside the next 30 days (Q3 is ~November), so the near-term binary is a corporate-action date rather than a numbers date. The observable positioning items are the $1.944B ATM authorisation signed 2026-08-13, the 2026-12-08 final SpaceX IPO lockup release that closes the staggered listed-space supply schedule begun with the 2026-08-06 unlock of 911.5M shares, and an analyst average of $112.94 sitting far above a $68.28 close with zero Sell ratings.
Catalyst Calendar (next 30 days)
- 2026-09-24 — Iridium special meeting, 8:30 a.m. ET, virtual (set in the S-4/A filed 2026-08-24; record date 2026-08-21).
- ~2026-09 (est.) — S-4 effectiveness and mailing of the definitive proxy statement/prospectus to Iridium holders.
- ~2026-09 (est., dates TBD) — Electron missions from Launch Complex 1: HawkEye 360 six-satellite, BlackSky Gen-3, LOXSAT 1 (Eta Space / NASA Tipping Point).
- 2026-12-08 — final SpaceX IPO lockup release. Outside the window; relevant to listed-space float conditions.
Elapsed catalysts
- ~2026-09 (est.) — FCC action on the Iridium licence-transfer applications filed 2026-08-10; the remaining substantive regulatory gate after the 2026-08-12 HSR expiry. (passed 14d ago)
- ~2026-Q4 (est.) — Neutron pad delivery and debut launch attempt, now qualified by Beck's 2026-08-24 comment. Outside the 30-day window but the item the EBITDA path hangs on. (passed 2d ago)
What Would Change Our Mind
The upside flip is a schedule, not a headline: a dated Neutron pad-delivery announcement with a launch attempt named inside 2026 would make Spice's EBITDA claim gradeable within two quarters and would give the tape something the August contract run could not. A first disclosed task order under NITE-STAR or NSSL Phase 3 Lane 1 — against the $12M of SDN-B orders announced 2026-08-18 — would convert shared ceilings into revenue evidence. A weekly close back above $83, the level of Piper Sandler's 2026-07-16 Neutral cap, would put price back inside the lower half of the published target band and argue the de-rating has run.
The downside condition is a weekly close below $64: that breaks under the low end of the published 18-analyst band and leaves the collar floor at $67.50 as resistance rather than support, with the Iridium stock leg then sitting at the 0.4000 maximum. The second condition is a catalyst that comes and goes — the 2026-09-24 vote clearing with no FCC grant behind it and no dated Neutron pad delivery by the Q3 print would leave the $3.6B bridge carried against equity supply and nothing else, which is the configuration that turns the label from saturated to dead.
Correlation Notes
IRDM is now a direct function of RKLB below the collar floor: with the ratio fixed at 0.4000 beneath a $67.50 reference price, the stock leg stops floating and Iridium trades as a levered proxy on the acquirer. Inference, not measurement: cash-and-stock deals of this shape attract merger-arb hedging in the acquirer's shares, and a static hedge ratio makes that flow mechanical rather than discretionary — a supply channel that grows as the vote and close approach.
The name still trades with the high-beta unprofitable-growth cohort rather than with the primes it was co-awarded alongside on 2026-08-17; the 2026-08-20 back-up in long-end yields hit it the same week its best policy headline in thirteen years landed. Space-sector ETF flows (UFO, ARKX, FSPC) and the SpaceX lockup schedule running to 2026-12-08 set the passive and float conditions for the whole listed complex, so single-name news has been clearing into a sector bid that is not currently there.
Notes
- 2026-04-18: seed: Serenity/attention list
- 2026-05-20: $3B ATM equity program filed with 16 banks — discretionary supply ceiling near record highs; this is a NEW structural negative the original re-entry gate did not price. Track 8-K/424B5 for actual issuance volume.
- 2026-06-05: S&P declined to create a SpaceX index-inclusion catalyst — removes the speculation bid the proxy basket front-ran; space complex crashed on the news.
- 2026-07-16: Piper Sandler initiated Neutral, PT $83 — FIRST post-Iridium coverage launch and it landed BELOW spot and below the entire 6-raise June 30 cluster ($96 Cantor floor, $130 Citizens/Roth ceiling). Target band now brackets price instead of sitting above it. A second Neutral or a downgrade from an existing bull confirms the raise cycle is over.
- Iridium consideration is $27.00 cash plus a collared exchange ratio: 0.4000 at or below a $67.50 ten-day VWAP, 0.2400 at or above $112.50. Outside date 2027-06-28.
- The collar reference price is measured over the ten trading days ending two full trading days before the first effective time — at closing, not at the shareholder vote.
- Guided Q3 basic weighted shares of 641M include roughly 41M Series A Convertible Participating Preferred, so the figure is not comparable to common shares outstanding.
- The $981M NITE-STAR and $17B NSSL Phase 3 Lane 1 figures are shared IDIQ ceilings across several providers, not Rocket Lab awards; delivery and task orders are the conversion measure.
- Incremental ATM issuance surfaces only in 10-Q, 8-K and 424B5 filings, never in press releases. Neutron has not flown; pad delivery moved from 2025 and again from mid-2026.
- Five-year beta 2.63. The company goes quiet in the blackout window before each quarterly release, so financing and schedule news tends to surface in the release itself.
Related · shared themes
IRDM
Iridium Communications Inc
Deal-arb: $27.00 cash plus a collared RKLB stock leg marks a $54.00 package against the 2026-08-24 close of $47.30, a 12.41% discount. The S-4/A filed 2026-08-24 finally dated the special meeting (2026-09-24), but RKLB at $68.28 sits just 1.16% above the $67.50 collar floor — below it the package floats one-for-one with the acquirer.
ASTS
AST SpaceMobile, Inc.
Deployment-cadence leg goes dead: the 2026-08-24 close of $62.35 (-9.2%, per GuruFocus) erased the 08-21 reclaim and broke below the 08-20 intraday low of $62.89, with BlueBirds 14/15/16 still undated 15 days after "ready to ship shortly." At $62.35 the tape prices below even Barclays' $65 Underweight target and below the $79.57 conversion price on the 2034 notes.
PL
Planet Labs PBC
Every reported close since 8/14 has stepped down — $24.69 to $22.17 on 8/20 — the 50-day/200-day gap widened to $25.53 vs $26.55, and the 8/20 low of $21.57 sat four cents above the 8/3 close. The unrevised 6/4 guide (FY27 $425–441M, Q2 $102–107M) is the last figure not marked down with the tape; the 9/3 Q2 FY27 print is the binary.
SPCX
SpaceX (Space Exploration Technologies Corp.)
Flight 14's ship catch is deferred (Musk, 2026-08-20); the mission is now a first orbital-class flight with ~20 Starlink V3, FCC window opening 2026-08-28. NVIDIA's 2026-08-24 release dated orbital compute — Starmind gen-1 on Vera Rubin NVL72 — to Q4 2027. Price sat back on the $135 IPO price at the 2026-08-24 close, with no close above $146.15 since 2026-08-12; the ~2026-09-09 tranche is the next supply test.
See also · stocks to watch